Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Total Current Liabilities (2019 - 2025)

Pulmonx (LUNG) has disclosed Total Current Liabilities for 7 consecutive years, with $22.9 million as the latest value for Q3 2025.

  • Quarterly Total Current Liabilities changed N/A to $22.9 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $22.9 million through Sep 2025, changed N/A year-over-year, with the annual reading at $24.4 million for FY2024, 5.53% up from the prior year.
  • Total Current Liabilities for Q3 2025 was $22.9 million at Pulmonx, up from $22.4 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $24.4 million in Q4 2024, with the low at $14.0 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $19.5 million, with a median of $19.5 million recorded in 2022.
  • The sharpest move saw Total Current Liabilities soared 40.11% in 2021, then dropped 3.59% in 2023.
  • Over 5 years, Total Current Liabilities stood at $17.6 million in 2021, then rose by 5.37% to $18.5 million in 2022, then rose by 25.23% to $23.2 million in 2023, then rose by 5.53% to $24.4 million in 2024, then fell by 6.38% to $22.9 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $22.9 million, $22.4 million, and $24.4 million for Q3 2025, Q2 2025, and Q4 2024 respectively.